Last reviewed · How we verify
ISMIGEN
At a glance
| Generic name | ISMIGEN |
|---|---|
| Also known as | Polyvalent Mechanical Bacterial Lysate - PMBL, Polyvalent Mechanical Bacterial Lysate (PMBL), Polyvalent mechanical bacterial lysate (PMBL) |
| Sponsor | Lallemand Pharma AG |
| Modality | Biologic |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effect of Bacterial Lysate on Nasal Carriage of Staphylococcus Aureus (PHASE3)
- The Influence of Nonspecific Immunostimulation on Changes in the Concentration of iNKT Cells (PHASE3)
- Efficacy Of Bacterial Lysate In Children With Allergic Rhinitis (PHASE3)
- Efficacy Of Bacterial Lysate In Asthmatic Children (PHASE3)
- Advanced Immunological Approach in COPD Exacerbation (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |